About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT03891602

DECIDE: Developing Tools for Lung Cancer Screening Discussion Improvement

The purpose of this study is to learn about discussion between clinicians and their patients related to lung screening. Survey answers will be collected from both clinicians and their patients.

Lead sponsor: Hackensack Meridian Health•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Hackensack Meridian Health

Collaborators

National Cancer Institute (NCI)
Indiana University
University of North Carolina
Memorial Sloan Kettering Cancer Center
Kaiser Permanente

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•CLINICIANS:
•Clinician (physician, nurse practitioner, or physician assistant)
•Practicing in a KPWA primary care clinic
•Having a patient panel with \>/= 10 lung cancer screening eligible patients
•PATIENTS (Quantitative Phase):
•Age 55-80 years
•\>/= 30 pack-year tobacco smoking history
•Current smoker or former smoker who has quit within the past 15 years
•Documented SDM lung cancer screening discussion during a recent clinic visit

Exclusion Criteria

•PATIENTS:
•Significant comorbidities (Charlson Comorbidity Index \>/=3)
•Lung cancer diagnosis

Related studies

Cigarette Filter Study

NCT07348679 · Smoking ( Cigarette)

RECRUITINGPhase 4

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

NCT06598397 · Human Immunodeficiency Virus (HIV), Smoking Cessation

RECRUITINGPhase 2

Cannabidiol for Reducing Cigarette Use

NCT06218056 · Tobacco Use Disorder, Tobacco Smoking, and more

Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers

NCT06372899 · E-cigarette Use, Cigarette Smoking, and more

Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain

NCT07080788 · Smoking Cessation Intervention, Pain, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 23, 2024Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment654

Start dateMar 2019

Last updatedAug 23, 2024

Condition

Smoking Smoking, Tobacco Smoking, Cigarette Lung Cancer

Locations shown

Kaiser Permanente Washington Health Research Institute

Seattle, Washington

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 23, 2024Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions